
NeurOn Therapeutics is an early-stage biotechnology company focused on developing personalized therapies for neurological disorders by digitally mapping brain responses. Their mission is to accelerate digital neurotechnology for personalized medicine, aiming to provide accessible digital therapies to patients worldwide. They are redefining neurorehabilitation through cognitive-explicit therapeutics, creating a platform for cognitive rehabilitation that emphasizes the importance of time in recovery. Their vision is to tailor neurotechnology for individual brain health, leveraging neuroplasticity to aid recovery after brain injury.

NeurOn Therapeutics is an early-stage biotechnology company focused on developing personalized therapies for neurological disorders by digitally mapping brain responses. Their mission is to accelerate digital neurotechnology for personalized medicine, aiming to provide accessible digital therapies to patients worldwide. They are redefining neurorehabilitation through cognitive-explicit therapeutics, creating a platform for cognitive rehabilitation that emphasizes the importance of time in recovery. Their vision is to tailor neurotechnology for individual brain health, leveraging neuroplasticity to aid recovery after brain injury.